Cite
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
MLA
Mandisa Singata-Madliki, et al. “Effects of Injectable Contraception with Depot Medroxyprogesterone Acetate or Norethisterone Enanthate on Estradiol Levels and Menstrual, Psychological and Behavioral Measures Relevant to HIV Risk: The WHICH Randomized Trial.” PLoS ONE, vol. 19, no. 3, Jan. 2024, p. e0295764. EBSCOhost, https://doi.org/10.1371/journal.pone.0295764&type=printable.
APA
Mandisa Singata-Madliki, Jenni Smit, Mags Beksinska, Yusentha Balakrishna, Chanel Avenant, Ivana Beesham, Ishen Seocharan, Joanne Batting, Janet P Hapgood, & G Justus Hofmeyr. (2024). Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS ONE, 19(3), e0295764. https://doi.org/10.1371/journal.pone.0295764&type=printable
Chicago
Mandisa Singata-Madliki, Jenni Smit, Mags Beksinska, Yusentha Balakrishna, Chanel Avenant, Ivana Beesham, Ishen Seocharan, Joanne Batting, Janet P Hapgood, and G Justus Hofmeyr. 2024. “Effects of Injectable Contraception with Depot Medroxyprogesterone Acetate or Norethisterone Enanthate on Estradiol Levels and Menstrual, Psychological and Behavioral Measures Relevant to HIV Risk: The WHICH Randomized Trial.” PLoS ONE 19 (3): e0295764. doi:10.1371/journal.pone.0295764&type=printable.